PER 0.00% 13.5¢ percheron therapeutics limited

Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-78

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,519 Posts.
    lightbulb Created with Sketch. 1446
    https://themarketherald.com.au/antisense-therapeutics-asxanp-revises-trial-plan-for-muscular-dystrophy-treatment-2022-09-07/?utm_source=threadview%20tmh%20widget&utm_medium=widget&utm_campaign=threadview%20tmh%20widget%20%7C%20click&utm_content=https://hotcopper.com.au/threads/ann-atl1102-revised-plans-accelerate-reporting-of-unblinded-data.6945031/page-76?post_id=63571412&utm_term=ANP
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.